CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,998,341 | -3.8% | 135,721 | +6.5% | 0.00% | -25.0% |
| Q2 2023 | $4,155,821 | -12.9% | 127,401 | -6.1% | 0.00% | 0.0% |
| Q1 2023 | $4,772,362 | -37.1% | 135,617 | -18.1% | 0.00% | -33.3% |
| Q4 2022 | $7,591,503 | +7.4% | 165,681 | +13.5% | 0.01% | -14.3% |
| Q3 2022 | $7,070,000 | +125.2% | 145,923 | +8.1% | 0.01% | +250.0% |
| Q1 2021 | $3,140,000 | +1.2% | 135,000 | -9.6% | 0.00% | 0.0% |
| Q4 2020 | $3,102,000 | -5.8% | 149,258 | -1.8% | 0.00% | -33.3% |
| Q3 2020 | $3,292,000 | +11.0% | 152,058 | +20.8% | 0.00% | 0.0% |
| Q2 2020 | $2,966,000 | +102.3% | 125,841 | +1.2% | 0.00% | +50.0% |
| Q1 2020 | $1,466,000 | +12.9% | 124,385 | +1.6% | 0.00% | +100.0% |
| Q4 2019 | $1,299,000 | +27.7% | 122,422 | +36.9% | 0.00% | 0.0% |
| Q3 2019 | $1,017,000 | +17.8% | 89,397 | +16.5% | 0.00% | 0.0% |
| Q2 2019 | $863,000 | +41.0% | 76,730 | +1.4% | 0.00% | 0.0% |
| Q1 2019 | $612,000 | +28.0% | 75,675 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $478,000 | -35.8% | 75,675 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $745,000 | +13.6% | 75,675 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $656,000 | +10.3% | 79,075 | -4.4% | 0.00% | 0.0% |
| Q1 2018 | $595,000 | -11.7% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $674,000 | -43.8% | 82,675 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,199,000 | +19.9% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000,000 | -5.8% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,062,000 | +5.7% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,005,000 | +32.4% | 82,675 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $759,000 | -3.3% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $785,000 | +34.6% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $583,000 | -52.6% | 82,675 | -29.7% | 0.00% | -50.0% |
| Q4 2015 | $1,230,000 | +122.4% | 117,575 | +42.2% | 0.00% | +100.0% |
| Q3 2015 | $553,000 | -0.5% | 82,675 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $556,000 | -35.6% | 82,675 | -26.2% | 0.00% | 0.0% |
| Q1 2015 | $864,000 | 0.0% | 111,975 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $864,000 | +104.3% | 111,975 | -6.7% | 0.00% | 0.0% |
| Q3 2014 | $423,000 | -26.3% | 120,075 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $574,000 | -17.2% | 120,075 | +53.8% | 0.00% | 0.0% |
| Q1 2014 | $693,000 | +83.3% | 78,075 | +38.0% | 0.00% | 0.0% |
| Q4 2013 | $378,000 | -13.5% | 56,575 | -1.7% | 0.00% | 0.0% |
| Q3 2013 | $437,000 | – | 57,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |